Mediclinic International PLC (LON:MDC) Receives GBX 394.20 Average Target Price from Brokerages

Shares of Mediclinic International PLC (LON:MDC) have been assigned an average rating of “Hold” from the six brokerages that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is GBX 394.20 ($5.19).

A number of equities analysts have weighed in on the company. UBS Group lowered Mediclinic International to a “neutral” rating and upped their target price for the stock from GBX 385 ($5.06) to GBX 400 ($5.26) in a research note on Tuesday, November 26th. Jefferies Financial Group upped their target price on Mediclinic International from GBX 422 ($5.55) to GBX 457 ($6.01) and gave the stock a “buy” rating in a research note on Friday, November 29th.

LON MDC traded up GBX 8.50 ($0.11) during trading on Tuesday, reaching GBX 403.80 ($5.31). The company’s stock had a trading volume of 1,652,046 shares, compared to its average volume of 1,610,000. The stock has a market capitalization of $2.98 billion and a PE ratio of 23.61. The company has a debt-to-equity ratio of 78.63, a current ratio of 1.83 and a quick ratio of 1.65. The firm has a fifty day moving average of GBX 385.24 and a 200 day moving average of GBX 341.46. Mediclinic International has a one year low of GBX 288.30 ($3.79) and a one year high of GBX 410.30 ($5.40).

The firm also recently announced a dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Thursday, December 5th will be paid a GBX 3.20 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, December 5th. This represents a yield of 0.85%. Mediclinic International’s dividend payout ratio is currently 0.47%.

About Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates.

Featured Article: Stop Order Uses For Individual Investors

Analyst Recommendations for Mediclinic International (LON:MDC)

Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with's FREE daily email newsletter.